Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells

Journal of Lipid Research

Volumn 52, Issue 4, 2011, Pages 782-793

  Golej, Deidre L ^a   Askari, Bardia ^a   Kramer, Farah ^a   Barnhart, Shelley ^a   Vivekanandan Giri, Anuradha ^b   Pennathur, Subramaniam ^b   Bornfeldt, Karin E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Eicosanoid; Fatty acid; Vascular biology

Indexed keywords

ARACHIDONIC ACID; ARACHIDONOYL COENZYME A; INTERLEUKIN 1BETA; LONG CHAIN ACYL COENZYME A SYNTHETASE 1; LONG CHAIN ACYL COENZYME A SYNTHETASE 4; LONG CHAIN FATTY ACID COENZYME A LIGASE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PROSTAGLANDIN E2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE; HUMAN; HUMAN CELL; LONG CHAIN ACYL COENZYME A SYNTHETASE 4 GENE; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION;

ARTERIES; BLOTTING, WESTERN; CELLS, CULTURED; COENZYME A LIGASES; DINOPROSTONE; GENETIC VECTORS; HUMANS; ISOENZYMES; MYOCYTES, SMOOTH MUSCLE; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953306432     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M013292     Document Type: Article

References (47)

1. Natarajan, R., and J. L. Nadler. 2004. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24: 1542-1548.
2. Smyth, E. M., T. Grosser, M. Wang, Y. Yu, and G. A. FitzGerald. 2009. Prostanoids in health and disease. J. Lipid Res. 50 (Suppl): 423-428.
3. Wang, M., W. L. Song, Y. Cheng, and G. A. Fitzgerald. 2008. Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J. Intern. Med. 263: 500-505.
4. Bäck, M., and G. K. Hansson. 2006. Leukotriene receptors in atherosclerosis. Ann. Med. 38: 493-502.
5. Kobayashi, T., Y. Tahara, M. Matsumoto, M. Iguchi, H. Sano, T. Murayama, H. Arai, H. Oida, T. Yurugi-Kobayashi, J. K. Yamashita, et al. 2004. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J. Clin. Invest. 114: 784-794. (Pubitemid 39578737)
6. Wang, M., A. M. Zukas, Y. Hui, E. Ricciotti, E. Puré, and G. A. FitzGerald. 2006. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc. Natl. Acad. Sci. USA. 103: 14507-14512.
7. Doran, A. C., N. Meller, and C. A. McNamara. 2008. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28: 812-819.
8. Graves, L. M., K. E. Bornfeldt, J. S. Sidhu, G. M. Argast, E. W. Raines, R. Ross, C. C. Leslie, and E. G. Krebs. 1996. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J. Biol. Chem. 271: 505-511.
9. Libby, P., S. J. Warner, and G. B. Friedman. 1988. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81: 487-498.
10. Bornfeldt, K. E., J. S. Campbell, H. Koyama, G. M. Argast, C. C. Leslie, E. W. Raines, E. G. Krebs, and R. Ross. 1997. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. J. Clin. Invest. 100: 875-885. (Pubitemid 27371706)
11. Coleman, R. A., T. M. Lewin, C. G. Van Horn, and M. R. Gonzalez-Baró. 2002. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways? J. Nutr. 132: 2123-2126.
12. Lewin, T. M., J. H. Kim, D. A. Granger, J. E. Vance, and R. A. Coleman. 2001. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J. Biol. Chem. 276: 24674-24679.
13. Watkins, P. A., D. Maiguel, Z. Jia, and J. Pevsner. 2007. Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome. J. Lipid Res. 48: 2736-2750. (Pubitemid 350272858)
14. Kang, M. J., T. Fujino, H. Sasano, H. Minekura, N. Yabuki, H. Nagura, H. Iijima, and T. T. Yamamoto. 1997. A novel arachidonate-preferring acyl-CoA synthetase is present in steroidogenic cells of the rat adrenal, ovary, and testis. Proc. Natl. Acad. Sci. USA. 94: 2880-2884.
15. Meloni, I., M. Muscettola, M. Raynaud, I. Longo, M. Bruttini, M. P. Moizard, M. Gomot, J. Chelly, V. des Portes, J. P. Fryns, et al. 2002. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat. Genet. 30: 436-440.
16. Mashek, D. G., K. E. Bornfeldt, R. A. Coleman, J. Berger, D. A. Bernlohr, P. Black, C. C. DiRusso, S. A. Farber, W. Guo, N. Hashimoto, et al. 2004. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J. Lipid Res. 45: 1958-1961. (Pubitemid 40990889)
17. Askari, B., J. E. Kanter, A. M. Sherrid, D. L. Golej, A. T. Bender, J. Liu, W. A. Hsueh, J. A. Beavo, R. A. Coleman, and K. E. Bornfeldt. 2007. Rosiglitazone inhibits acyl-CoA synthetase activity and fatty acid partitioning to diacylglycerol and triacylglycerol via a peroxisome proliferator-activated receptor-gamma-independent mechanism in human arterial smooth muscle cells and macrophages. Diabetes. 56: 1143-1152.
18. Suzuki, L. A., M. Poot, R. G. Gerrity, and K. E. Bornfeldt. 2001. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes. 50: 851-860.
19. Perez-Reyes, N., C. L. Halbert, P. P. Smith, E. P. Benditt, and J. K. McDougall. 1992. Immortalization of primary human smooth muscle cells. Proc. Natl. Acad. Sci. USA. 89: 1224-1228.
20. Garton, K. J., N. Ferri, and E. W. Raines. 2002. Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors. Biotechniques. 32: 830, 832, 834 passim.
21. Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132: 365-386.
22. Haynes, C. A., J. C. Allegood, K. Sims, E. W. Wang, M. C. Sullards, and A. H. Merrill, Jr. 2008. Quantitation of fatty acyl-coenzyme As in mammalian cells by liquid chromatography-electrospray ionization tandem mass spectrometry. J. Lipid Res. 49: 1113-1125.
23. Golovko, M. Y., and E. J. Murphy. 2004. An improved method for tissue long-chain acyl-CoA extraction and analysis. J. Lipid Res. 45: 1777-1782.
24. Lewin, T. M., S. Wang, C. A. Nagle, C. G. Van Horn, and R. A. Coleman. 2005. Mitochondrial glycerol-3-phosphate acyltransferase-1 directs the metabolic fate of exogenous fatty acids in hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288: E835-844.
25. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
26. Askari, B., M. A. Carroll, M. Capparelli, F. Kramer, R. G. Gerrity, and K. E. Bornfeldt. 2002. Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J. Biol. Chem. 277: 36338-36344.
27. Hamilton, J. G., and K. Comai. 1984. Separation of neutral lipids and free fatty acids by high-performance liquid chromatography using low wavelength ultraviolet detection. J. Lipid Res. 25: 1142-1148. (Pubitemid 15207098)
28. Schmidlin, F., S. Loeffler, C. Bertrand, Y. Landry, and J. P. Gies. 2000. PLA2 phosphorylation and cyclooxygenase-2 induction, through p38 MAP kinase pathway, is involved in the IL-1β-induced bradykinin B2 receptor gene transcription. Naunyn Schmiedebergs Arch. Pharmacol. 361: 247-254.
29. Kim, J. H., T. M. Lewin, and R. A. Coleman. 2001. Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J. Biol. Chem. 276: 24667-24673.
30. Van Horn, C. G., J. M. Caviglia, L. O. Li, S. Wang, D. A. Granger, and R. A. Coleman. 2005. Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6. Biochemistry. 44: 1635-1642.
31. Maloberti, P. M., A. B. Duarte, U. D. Orlando, M. E. Pasqualini, A. R. Solano, C. López-Otín, and E. J. Podestá. 2010. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS ONE. 5: e15540.
32. Cao, Y., E. Traer, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1998. Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics. 49: 327-330.
33. Cho, Y. Y., M. J. Kang, H. Sone, T. Suzuki, M. Abe, M. Igarashi, T. Tokunaga, S. Ogawa, Y. A. Takei, T. Miyazawa, et al. 2001. Abnormal uterus with polycysts, accumulation of uterine prostaglandins, and reduced fertility in mice heterozygous for acyl-CoA synthetase 4 deficiency. Biochem. Biophys. Res. Commun. 284: 993-997. (Pubitemid 32924747)
34. Liang, Y. C., C. H. Wu, J. S. Chu, C. K. Wang, L. F. Hung, Y. J. Wang, Y. S. Ho, J. G. Chang, and S. Y. Lin. 2005. Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase. World J. Gastroenterol. 11: 2557-2563.
35. Kudo, T., T. Tamagawa, M. Kawashima, N. Mito, and S. Shibata. 2007. Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet. J. Biol. Rhythms. 22: 312-323. (Pubitemid 47077308)
36. Kotronen, A., H. Yki-Järvinen, A. Aminoff, R. Bergholm, K. H. Pietiläinen, J. Westerbacka, P. J. Talmud, S. E. Humphries, A. Hamsten, B. Isomaa, et al. 2009. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur. J. Endocrinol. 160: 593-602.
37. Sung, Y. K., S. Y. Hwang, M. K. Park, H. I. Bae, W. H. Kim, J. C. Kim, and M. Kim. 2003. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma. Cancer Sci. 94: 421-424. (Pubitemid 36790473)
38. Cao, Y., K. B. Dave, T. P. Doan, and S. M. Prescott. 2001. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. Cancer Res. 61: 8429-8434.
39. Piccini, M., F. Vitelli, M. Bruttini, B. R. Pober, J. J. Jonsson, M. Villanova, M. Zollo, G. Borsani, A. Ballabio, and A. Renieri. 1998. FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. Genomics. 47: 350-358. (Pubitemid 28110647)
40. Bhat, S. S., K. R. Schmidt, S. Ladd, K. C. Kim, C. E. Schwartz, R. J. Simensen, B. R. DuPont, R. E. Stevenson, and A. K. Srivastava. 2006. Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenet. Genome Res. 112: 170-175.
41. Meloni, I., V. Parri, R. De Filippis, F. Ariani, R. Artuso, M. Bruttini, E. Katzaki, I. Longo, F. Mari, C. Bellan, et al. 2009. The XLMR gene ACSL4 plays a role in dendritic spine architecture. Neuroscience. 159: 657-669.
42. Westerbacka, J., M. Kolak, T. Kiviluoto, P. Arkkila, J. Sirén, A. Hamsten, R. M. Fisher, and H. Yki-Järvinen. 2007. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes. 56: 2759-2765. (Pubitemid 350044919)
43. Kirkby, B., N. Roman, B. Kobe, S. Kellie, and J. K. Forwood. 2010. Functional and structural properties of mammalian acyl-coenzyme A thioesterases. Prog. Lipid Res. 49: 366-377.
44. Cao, Y., T. Pearman, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 2000. Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl. Acad. Sci. USA. 97: 11280-11285.
45. Cipollone, F., B. Rocca, and C. Patrono. 2004. Cyclooxygenase-2 expression and inhibition in atherothrombosis. Arterioscler. Thromb. Vasc. Biol. 24: 246-255. (Pubitemid 38197575)
46. Moreno, J. J. 2009. Differential effects of arachidonic and eicosapentaenoic acid-derived eicosanoids on polymorphonuclear transmigration across endothelial cell cultures. J. Pharmacol. Exp. Ther. 331: 1111-1117.
47. Hertz, A. L., A. T. Bender, K. C. Smith, M. Gilchrist, P. S. Amieux, A. Aderem, and J. A. Beavo. 2009. Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA. 106: 21978-21983.